Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.

P Bilotta, S Favilli - Arzneimittel-forschung, 1988 - europepmc.org
A multicenter trial was conducted in 267 centers in Italy to evaluate the efficacy, acceptability
and safety of a monophasic oral contraceptive containing 30 micrograms ethinyl estradiol …

Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel

H Rekers - Acta obstetricia et gynecologica Scandinavica, 1988 - Wiley Online Library
A clinical trial was conducted at 47 centers in 11 countries to assess the efficacy and
acceptability of a monophasic oral contraceptive containing 30 g ethinyl estradiol and 150 g …

German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestradiol

J Nevinny‐Stickel - Acta Obstetricia et Gynecologica …, 1987 - Wiley Online Library
A multicenter trial was carried out by 13 independent German investigators to evaluate a
new oral contraceptive combination containing 0.150 mg desogestrel+ 0.020 mg …

A clinical comparison in Finland of two oral contraceptives containing 0.150 mg desogestrel in combination with 0.020 mg or 0.030 mg ethinylestradiol

R Tuimala, M Saranen… - Acta Obstetricia et …, 1987 - Wiley Online Library
The results of two open Finnish multicenter studies on the effects of two oral contraceptive
combinations containing 0.150 mg desogestrel+ 0.030 mg ethinylestradiol (EE) and 0.150 …

Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrel

K Fotherby - Contraception, 1995 - Elsevier
The clinical experience with a combined oral contraceptive (COC) containign 150 μg
desogestrel and 30 μg ethinylestradiol is reviewed. Fourteen clinical trials have been …

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.

S Golbs, R Domhardt, J Presl, M Ganev… - Methods and findings …, 2002 - europepmc.org
The efficacy and safety of the low dose monophasic oral contraceptive (OC) combination
containing 30 micrograms of ethinylestradiol (EE) and 2.0 mg of dienogest (DNG)(EE/DNG) …

A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl …

R Bannemerschult, JP Hanker, C Wünsch, P Fox… - Contraception, 1997 - Elsevier
The aim of the trial was to demonstrate the contraceptive efficacy of a new low dose oral
contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel and to observe …

Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol

P Lammers, M op ten Berg - Acta obstetricia et gynecologica …, 1991 - Taylor & Francis
Results are presented of a Phase III international multicentre trial to study the effect of a new
low-dose oral contraceptive (OC) containing 20 μg ethinylestradiol and 150 μg desogestrel …

Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl …

M ÅKerlund, A Rødez… - BJOG: An International …, 1993 - Wiley Online Library
Objective To compare two oral contraceptive pills, both containing 150 μg desogestrel, but
with either 20 μg (Mercilon®) or 30 μg (Marvelon®/Desolett®) ethinyl oestradiol (EE) …

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.

S Golbs, R Domhardt, S Radowicky… - Methods and findings …, 2002 - europepmc.org
The efficacy and safety of the low dose monophasic oral contraceptive (OC) combination
containing 30 micrograms of ethinylestradiol (EE) and 2.0 mg of dienogest (DNG)(EE/DNG) …